24/7 Market News Snapshot 25 February, 2025 – GT Biopharma Inc. Common Stock (NASDAQ:GTBP)

February 25, 2025

DENVER, Colo., 25 February, 2025 (247marketnews.com) – (NASDAQ:GTBP) are discussed in this article.
GT Biopharma Inc. (GTBP), recognized for its innovative work in the field of immuno-oncology, began trading today at $2.46 but has since seen a decline to $2.269, marking an approximate drop of 11.77%. The previous trading session concluded at $2.030, indicating increasing market volatility. Today’s trading activity has surged to 26.08 million shares, reflecting enhanced investor engagement and possibly indicating a mix of profit-taking and overall bearish sentiment among traders. Market observers should note critical support levels around $2.00 and resistance near the opening price as they monitor future price movements.

In addition to these market dynamics, GT Biopharma has made strides in strengthening its financial position. The company has finalized agreements for the exercise of existing warrants, which allow for the purchase of 302,069 shares at an exercise price of $4.35 per share, raising approximately $0.7 million in gross proceeds before fees and related expenses. These funds are designated for working capital and general corporate purposes as the company advances its proprietary TriKE® natural killer (NK) cell engager platform.

Moreover, in a strategic enhancement to investor relations, GT Biopharma will issue unregistered warrants for up to 604,138 shares of common stock in conjunction with the warrant exercises. These new warrants will feature an exercise price of $2.02 per share and encompass various terms, presenting investors with additional opportunities for engagement.

H.C. Wainwright & Co. will serve as the exclusive placement agent for this initiative, with the transaction expected to close around February 27, 2025, subject to standard conditions. As GT Biopharma continues to refine its focus on developing advanced cancer therapeutics, it remains dedicated to addressing pressing healthcare challenges through its innovative technology and strategic financial maneuvers.

Related news for (GTBP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.